Review: taking Symbicort and Serevent together


Summary

Drug interactions are reported among people who take Symbicort and Serevent together. This review analyzes the effectiveness and drug interactions between Symbicort and Serevent. It is created by eHealthMe based on reports of 90 people who take the same drugs from FDA and social media, and is updated regularly.

You are not alone

Join a support group for people who take Symbicort and Serevent >>>

Personalized health information

On eHealthMe you can find out what patients like me (same gender, age) reported their drugs and conditions on FDA and social media since 1977. Our tools are free and anonymous. 86 million people have used us. 300+ peer-reviewed medical journals have referenced our original studies. Start now >>>


Symbicort

Symbicort has active ingredients of budesonide; formoterol fumarate dihydrate. It is often used in asthma. (latest outcomes from Symbicort 25,817 users)

Serevent

Serevent has active ingredients of salmeterol xinafoate. It is often used in asthma. (latest outcomes from Serevent 12,659 users)

On Aug, 25, 2016

90 people who take Symbicort, Serevent are studied.


Number of reports submitted per year:

Symbicort and Serevent drug interactions.

Drug effectiveness over time:

Symbicort:
  • < 1 month: 0.0% - (0 of 0 people)
  • 1 - 6 months: 0.0% - (0 of 1 people)
  • 6 - 12 months: 0.0% - (0 of 0 people)
  • 1 - 2 years: 0.0% - (0 of 0 people)
  • 2 - 5 years: 0.0% - (0 of 0 people)
  • 5 - 10 years: 0.0% - (0 of 0 people)
  • 10+ years: 0.0% - (0 of 0 people)
  • not specified: 0.0% - (0 of 0 people)
Serevent:
  • < 1 month: 0.0% - (0 of 0 people)
  • 1 - 6 months: 0.0% - (0 of 1 people)
  • 6 - 12 months: 0.0% - (0 of 0 people)
  • 1 - 2 years: 0.0% - (0 of 0 people)
  • 2 - 5 years: 0.0% - (0 of 0 people)
  • 5 - 10 years: 0.0% - (0 of 0 people)
  • 10+ years: 0.0% - (0 of 0 people)
  • not specified: 0.0% - (0 of 0 people)

Drug effectiveness by gender:

Symbicort:
  • female: 0.0% - (0 of 0 people)
  • male: 0.0% - (0 of 1 people)
Serevent:
  • female: 0.0% - (0 of 0 people)
  • male: 0.0% - (0 of 1 people)

Drug effectiveness by age:

Symbicort:
  • 0-1: 0.0% - (0 of 0 people)
  • 2-9: 0.0% - (0 of 0 people)
  • 10-19: 0.0% - (0 of 0 people)
  • 20-29: 0.0% - (0 of 0 people)
  • 30-39: 0.0% - (0 of 0 people)
  • 40-49: 0.0% - (0 of 0 people)
  • 50-59: 0.0% - (0 of 0 people)
  • 60+: 0.0% - (0 of 1 people)
Serevent:
  • 0-1: 0.0% - (0 of 0 people)
  • 2-9: 0.0% - (0 of 0 people)
  • 10-19: 0.0% - (0 of 0 people)
  • 20-29: 0.0% - (0 of 0 people)
  • 30-39: 0.0% - (0 of 0 people)
  • 40-49: 0.0% - (0 of 0 people)
  • 50-59: 0.0% - (0 of 0 people)
  • 60+: 0.0% - (0 of 1 people)

Most common drug interactions over time *:

< 1 month:
  • asthma
  • blood potassium decreased
  • dehydration
  • dyspnoea
  • nasopharyngitis
  • upper respiratory tract inflammation
  • adverse event
  • chest discomfort
  • hot flush
  • musculoskeletal chest pain
1 - 6 months:
  • adverse event
  • angina unstable
  • arthralgia
  • dyspnoea
  • arteriosclerosis
  • asthma
  • gait disturbance
  • status asthmaticus
  • stent placement
1 - 2 years:
  • asthma
2 - 5 years:
  • asthma
  • liver disorder
  • osteonecrosis
  • alanine aminotransferase increased
  • aspartate aminotransferase increased
  • constipation
  • erythema
  • hepatic enzyme increased
  • hyperglycaemia
  • insomnia
not specified:
  • asthma
  • muscle spasms
  • asthenia
  • pneumonia
  • dyspnoea
  • chest pain
  • gastrooesophageal reflux disease
  • back pain
  • anaemia
  • arthralgia

Most common drug interactions by gender *:

female:
  • asthma
  • muscle spasms
  • asthenia
  • gastrooesophageal reflux disease
  • back pain
  • anaemia
  • liver disorder
  • pneumonia
  • urinary tract infection
  • rash
male:
  • dyspnoea
  • asthma
  • acute myocardial infarction
  • angina unstable
  • blood glucose increased
  • osteonecrosis
  • abasia
  • arthralgia
  • bursitis
  • cardiac failure congestive

Most common drug interactions by age *:

2-9:
  • abasia
  • arthralgia
  • bursitis
  • femur fracture
  • pain in extremity
  • stress fracture
  • cardiac disorder
10-19:
  • chest discomfort
  • dyspnoea
20-29:
  • abdominal pain lower
  • bladder dilatation
  • chest pain
  • dyspareunia
  • dysuria
  • pulmonary embolism
  • urinary tract infection
  • cushing's syndrome
  • forced expiratory volume decreased
  • middle insomnia
30-39:
  • osteonecrosis
  • arthralgia
  • asthma
  • gait disturbance
  • status asthmaticus
40-49:
  • haemoptysis
  • anaemia
  • cardiac arrest
  • cough
  • malaise
  • oropharyngeal pain
  • thrombocytopenia
  • asthenia
  • influenza like illness
  • asthma
50-59:
  • asthma
  • dyspnoea
  • adverse event
  • activities of daily living impaired
  • acute coronary syndrome
  • acute myocardial infarction
  • alopecia
  • angina unstable
  • anxiety
  • arteriosclerosis
60+:
  • dyspnoea
  • asthma
  • liver disorder
  • pneumonia
  • muscle spasms
  • blood glucose increased
  • cataract
  • adverse event
  • oropharyngeal pain
  • rash

* Approximation only. Some reports may have incomplete information.

How to use the study: print a copy of the study and bring it to your health teams to ensure drug risks and benefits are fully discussed and understood.

Do you take Symbicort and Serevent?

Can you answer these questions?

More questions for: Symbicort, Serevent

You may be interested in these reviews

More reviews for: Symbicort, Serevent

On eHealthMe, Symbicort (budesonide; formoterol fumarate dihydrate) is often used to treat asthma. Serevent (salmeterol xinafoate) is often used to treat asthma. Find out below the conditions the drugs are used for and how effective they are.

What is the drug used for and how effecitve is it:


NOTE: The study is based on active ingredients and brand name. Other drugs that have the same active ingredients (e.g. generic drugs) are NOT considered.

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only, and has not been supported by scientific studies or clinical trials unless otherwise stated. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

You may report adverse side effects to the FDA at http://www.fda.gov/medwatch/ or 1-800-FDA-1088 (1-800-332-1088).

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.